Clinical Partners has raised new debt facilities
Clinical Partners Ltd. has successfully restructured and upsized its debt facilities to better reflect the scale of the business. The company increased its original US$9.4 million facility, comprising a US$3.4 million term loan and a US$6 million revolving credit facility (RCF), to a US$27 million RCF.
The new facility was secured on improved pricing and with enhanced documentation flexibility, providing additional headroom to support the company’s long-term strategy, including organic and acquisitive growth, as well as indirectly supporting a dividend to shareholders.
Clinical Partners is a leading provider of mental health services, working both privately and with the National Health Service (NHS) to help people of all ages achieve improved mental health outcomes. Through in-person and remote appointments, the company connects thousands of patients with senior clinicians across a broad range of mental health conditions, including autism, attention deficit hyperactivity disorder (ADHD), anxiety and depression.
Oaklins Cavendish, one of Oaklins’ member firms in the UK, advised Clinical Partners in raising new debt facilities. The team supported the company throughout the process, helping to secure a structure aligned with its growth ambitions and long-term strategic objectives.
Talk to the deal team
David Fitzgerald
Oaklins Cavendish
Related deals
UKAT Group has acquired Bayberry Limited
UK Addiction Treatment (UKAT) Group, a leading UK provider of residential addiction, mental health and behavioral health treatment backed by Sullivan Street Partners, has acquired Bayberry Limited, a specialist mental health and wellbeing treatment provider. Joining UKAT enables Bayberry to preserve continuity of care for patients and referral partners, retain the strength of its clinical team and benefit from UKAT’s operational infrastructure, referral network and marketing channels. This partnership supports Bayberry’s next stage of development while preserving the qualities that differentiate its service offering.
Learn moreMedicija has acquired Saulės Šeimos Medicinos Centras
Medicija has acquired a 100% stake in Saulės Šeimos Medicinos Centras.
Learn moreQuimpharma has completed the divestiture of a product portfolio to Megalabs
Quimpharma has completed the divestiture of a product portfolio to Megalabs México.
Learn more